Programmed death ligand 1 (PD-L1) exosomes are important biomarkers of immune
activation in the initial stages of treatment and can predict clinical responses to PD-1 …

Programmed death-ligand 1 protein positive (PD-L1+) exosome is one of the most
prospective biomarkers for the diagnosis of cancer. However, the current methods for the …

Exosomes are lipid-bilayer-enclosed extracellular vehicles (EVs) derived from all cells and
circulating in the blood. Identification of cancer specific exosomes in body fluids has shown …

Tumor-derived exosomes play a vital role in the process of cancer development.
Quantitative analysis of exosomes and exosome-shuttled proteins would be of immense …

Biosensors developed through a sandwich approach have demonstrated favorable
detection performance for exosomal programmed cell death 1 ligand 1 (ExoPD-L1) …

Cancer-derived exosomes have recently emerged as potent candidates for diagnosis and
prognosis of breast cancer. As an example, programmed death ligand-1 positive (PD-L1+) …

Abstract Programmed death ligand-1 (PD-L1) positive extracellular vesicles (EVs)
subpopulation have recently emerged as potent candidates for clinical cancer diagnosis and …

Programmed cell death receptor 1 (PD‐L1) protein on exosomes (exosomal PD‐L1) is one
of the most promising biomarkers for cancer immunotherapy monitoring. However, current …

Exosomes derived vesicles and their surface anchored proteins by cells are extremely vital
in intercellular communication, immuno-stimulation, and so on, which are promising in …

Programmed cell death ligand 1 protein-positive (PD-L1+) exosomes have been found to be
a potential biomarker for the diagnosis of non-small cell lung cancer (NSCLC). However, the …